Beta Bionics (BBNX) vs Enovis (ENOV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Beta Bionics (BBNX) has outperformed Enovis (ENOV) over the past year, losing 21.2% versus a loss of 45.2%. Enovis is the larger company by market cap ($1.02 billion vs $951.1 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BBNX | ENOV |
|---|---|---|
| Share price | $17.63 | $17.69 |
| Market cap | $951.07M | $1.02B |
| 1-day change | +1.15% | +1.49% |
| YTD return | -42.80% | -34.57% |
| 1-year return | -21.24% | -45.15% |
| 5-year return | — | -79.99% |
| Forward P/E | — | 4.93 |
| EPS (TTM) | $-1.64 | $-19.23 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $32.71 | $34.28 |
| 52-week low | $8.80 | $16.70 |
| Distance from 52-week high | -46.10% | -48.40% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +35.00% | +112.44% |
| Average volume | 1.31M | 1.46M |
| Shares outstanding | 53.95M | 57.67M |
| Employees | 420 | 7,802 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BBNX has outperformed ENOV by 23.9 percentage points over the past year.
About Beta Bionics
BBNX stock →Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older.
Health Care · Medical/Dental Instruments · 420 employees
About Enovis
ENOV stock →Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments.
Health Care · Industrial Specialties · 7,802 employees
BBNX vs ENOV FAQ
Which is bigger, Beta Bionics or Enovis?
Enovis (ENOV) is larger, with a market capitalization of $1.02B compared with $951.07M for Beta Bionics (BBNX).
Which stock has performed better over the past year, BBNX or ENOV?
BBNX returned -21.24% over the past 12 months, compared with -45.15% for ENOV (price return, excluding dividends). Past performance does not predict future results.
Are Beta Bionics and Enovis in the same industry?
Both are in the Health Care sector, but in different industries: Medical/Dental Instruments for Beta Bionics and Industrial Specialties for Enovis.